Clin2
NCT07202000Possibly a fitRecruiting

Exercise and a drug to reduce inflammation for heart failure with preserved ejection fraction

Heart Failure With Preserved Ejection Fraction

Part of Heart & circulation clinical trials.

This trial tests whether combining exercise with a medication that blocks a protein called activin can reduce inflammation, improve heart function, and help with thinking in people with heart failure with preserved ejection fraction (HFpEF).

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
48 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You must be 40 years or older.
  • Your body mass index (BMI) must be 27 or higher.
  • You must have a type of heart failure called HFpEF, where your heart pumps normally but is stiff.
  • You need to be able to walk and do exercise tests like a 6-minute walk.
  • Your medications must be stable for at least 30 days before starting the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05464238Not yet recruiting
Exercise training for heart failure with preserved pumping function

This trial tests whether a structured exercise training program can improve symptoms and quality of life in people with heart failure with preserved ejection fraction (HFpEF), a condition where the heart pumps normally but is too stiff to fill properly. Participants will receive exercise training alongside their usual heart failure medications.

Heidelberg
NCT07795814Recruiting· Phase 2
Study of a new medicine for heart failure with preserved pumping function

This study tests an investigational medicine called EDG-15400 for people with a type of heart failure where the heart muscle is stiff and doesn't relax properly, even though the pumping function is normal. The goal is to see if the medicine improves symptoms and daily functioning.

Birmingham, Alabama
NCT05279742Enrolling by invitation· Phase 1/Phase 2
Study drug to boost a hormone system in HFpEF

This early-phase trial tests a treatment that aims to improve the “natriuretic peptide” hormone system in people with HFpEF (heart failure with preserved pumping strength). It may help reduce symptoms and improve heart and fluid pressure behavior, especially in certain related conditions like kidney disease.

Rochester, Minnesota
NCT07413198Recruiting
Combined home and clinic exercise coaching for heart failure

This trial tests a program that combines home-based and clinic-based exercise coaching to help people with heart failure get more active. It aims to improve health and quality of life.

Winston-Salem, North Carolina
NCT05582044Recruiting
Exercise using leg suction for heart failure with preserved function

This study tests whether a specific lower-body exercise method using negative pressure (leg suction) can improve symptoms and heart-related function in people with heart failure with preserved ejection fraction (HFpEF). You may also be offered screening if you are a healthy person, to compare results.

Kelowna, British Columbia
NCT05115890Recruiting
Testing blood-flow control in heart failure with preserved pumping

This study looks at how well blood flow is regulated in people with HFpEF, a type of heart failure where the heart squeezes normally but doesn’t fill properly. It may help researchers understand the cause of symptoms and how to improve treatment strategies.

Salt Lake City, Utah

Hear when a new Heart Failure With Preserved Ejection Fraction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.